Waldencast (WALD) CFO Manfredi acquired 79,289 shares
Insider transactions reported
Manuel Manfredi (Chief Financial Officer at Waldencast plc, WALD) reported that they acquired 79,289 shares on Jul 30, 2026. After these transactions the filing shows 118,933 shares held directly.
- Reporting person
- Manfredi Manuel
- Role
- Chief Financial Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Exercise or conversion of a derivative (M) | Class A Ordinary Shares1 | +79,289 | - | - | 118,933 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | Exercise or conversion of a derivative (M) | Restricted Stock UnitsOn 79,289 Class A Ordinary Shares1, 2, 3 | -79,289 | - | - | 0 direct |
Holdings before and after
- Class A Ordinary Shares: 39,644 to 118,933 direct
- Restricted Stock Units: 79,289 to 0 direct
Footnotes from the filing
- 1. Represents accelerated vesting of 79,289 outstanding restricted stock units ( RSUs ) held by the reporting person in connection with the completion of the Issuer's sale of its Obagi Medical dermatological skincare and aesthetics business on July 30, 2026. Effective on the date of completion of such sale, the reporting person transitioned from the Issuer to lead Obagi Medical.
- 2. Each RSU represents a contingent right to receive one Class A ordinary share, or an equivalent value in cash at the plan administrator's election.
- 3. On October 30, 2024, the reporting person was granted 118,933 RSUs, which would have vested over a three-year period as follows: (i) 39,644 on October 1, 2025; (ii) 39,644 on October 1, 2026; and (iii) 39,645 on October 1, 2027.
Transaction codes in this filing
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Manfredi report in this WALD Form 4?
Manuel Manfredi (Chief Financial Officer at Waldencast plc, WALD) reported that they acquired 79,289 shares on Jul 30, 2026. After these transactions the filing shows 118,933 shares held directly.
How many WALD shares does Manfredi hold after this filing?
The filing shows 118,933 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code M mean on an SEC Form 4?
Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
Historical context for WALD
Across the 27 sessions after earlier WALD headlines, the stock closed higher 12 times and lower 14 times, with a median move of 4.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WALD | SPY |
|---|---|---|---|
| Jul 31, 2026 | Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint | +1.2% | +0.7% |
| Jun 15, 2026 | Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel | -2.2% | +1.8% |
| Jun 1, 2026 | Waldencast Announces Sale of Obagi Medical to Bridgepoint | +48.8% | +0.3% |
| May 15, 2026 | Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting | -9.8% | -1.2% |
| May 14, 2026 | Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience | -1.2% | +0.8% |
| Apr 30, 2026 | Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* | +16.6% | +1.0% |
Earlier insider filings at WALD
- Market cap
- 30-day
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- Listed since
- 2021
Follow WALD and get a push notification the moment its next story breaks.